Revance Therapeutics Inc (RVNC)
3.99
-0.18
(-4.32%)
USD |
NASDAQ |
Nov 18, 16:00
4.08
+0.09
(+2.26%)
After-Hours: 20:00
Revance Therapeutics Price: 3.99 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2024 | 4.18 | 4.185 | 3.98 | 3.99 | 1.374M |
| Nov 15, 2024 | 4.30 | 4.30 | 4.135 | 4.17 | 1.213M |
| Nov 14, 2024 | 4.29 | 4.365 | 4.17 | 4.31 | 1.485M |
| Nov 13, 2024 | 4.12 | 4.285 | 4.00 | 4.24 | 1.991M |
| Nov 12, 2024 | 3.47 | 4.26 | 3.42 | 4.13 | 6.601M |
| Nov 11, 2024 | 3.75 | 3.90 | 3.36 | 3.45 | 6.275M |
| Nov 08, 2024 | 4.25 | 4.34 | 3.481 | 3.70 | 13.15M |
| Nov 07, 2024 | 5.80 | 5.90 | 5.73 | 5.78 | 1.536M |
| Nov 06, 2024 | 5.95 | 5.97 | 5.665 | 5.81 | 1.592M |
| Nov 05, 2024 | 5.80 | 5.90 | 5.733 | 5.84 | 654544.0 |
| Nov 04, 2024 | 5.80 | 5.85 | 5.64 | 5.81 | 1.024M |
| Nov 01, 2024 | 5.88 | 5.915 | 5.59 | 5.80 | 1.673M |
| Oct 31, 2024 | 5.92 | 5.94 | 5.835 | 5.90 | 1.418M |
| Oct 30, 2024 | 5.91 | 5.95 | 5.875 | 5.92 | 1.132M |
| Oct 29, 2024 | 5.90 | 5.96 | 5.85 | 5.91 | 1.125M |
| Oct 28, 2024 | 6.00 | 6.09 | 5.850 | 5.90 | 8.947M |
| Oct 25, 2024 | 5.34 | 5.34 | 4.68 | 4.70 | 2.827M |
| Oct 24, 2024 | 5.29 | 5.355 | 5.245 | 5.30 | 779303.0 |
| Oct 23, 2024 | 5.28 | 5.325 | 5.22 | 5.29 | 864811.0 |
| Oct 22, 2024 | 5.29 | 5.30 | 5.25 | 5.29 | 487115.0 |
| Oct 21, 2024 | 5.28 | 5.32 | 5.26 | 5.28 | 895013.0 |
| Oct 18, 2024 | 5.15 | 5.43 | 5.10 | 5.29 | 1.887M |
| Oct 17, 2024 | 5.24 | 5.28 | 5.13 | 5.18 | 1.173M |
| Oct 16, 2024 | 5.21 | 5.336 | 5.19 | 5.28 | 832302.0 |
| Oct 15, 2024 | 5.12 | 5.275 | 5.08 | 5.20 | 1.218M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.34
Minimum
Jun 26 2024
37.61
Maximum
May 09 2023
19.11
Average
20.30
Median
Price Benchmarks
| Recursion Pharmaceuticals Inc | 6.10 |
| Regeneron Pharmaceuticals Inc | 762.00 |
| MEI Pharma Inc | 2.875 |
| GlycoMimetics Inc | 0.4152 |
| Anebulo Pharmaceuticals Inc | 1.53 |
Price Related Metrics
| PS Ratio | 1.502 |
| Earnings Yield | -48.62% |
| Market Cap | 418.56M |